肝癌术后复发转移再切除治疗28例疗效分析  

Analysis of therapeutic effect of re-resection in 28 cases with recurrent hepatocellular cacinoma

作　　者：黄映明[1] 李伟道[1] 刘家隽[1] 殷子奇[1] 

机构地区：[1]重庆市肿瘤医院肝胆外科,400030

出　　处：《重庆医学》2005年第9期1385-1386,共2页Chongqing medicine

摘　　要：目的评价再手术在肝癌复发治疗中的地位。方法回顾性分析我院28例肝癌术后复发转移再手术治疗的随访资料。结果本组28例复发肝癌行再切除手术34例次,无手术死亡。再切除术后1、3、5年生存率分别为78.6%(22/28)、35.7(10/28)、21.4%(6/28),中位生存时间26个月。第1次手术后1、3、5年生存率分别为96.4%(27/28)、78.6%(22/28)、46.4%(13/28),中位生存时间56个月。1例患者术后生存长达45年。结论肝癌术后应加强监测,早期发现病灶。手术再切除是肝癌术后复发的首选治疗方法,可明显延长患者术后生存时间。Objective To evaluate the therapeutic effect of re-resection in the treatment of recurrent hepatocellular carcinoma （HCC）. Methods Retrospective analysis of 28 cases with recurrent HCC re-resected were followed up. Results Twenty-eight patients with recurrent HCC were undergone 34 re- resection operations with no operative death. The survival rate of 1,3,5 year from re-resected operation were 78. 6% （22/28）,35. 7% （10/28）and 21. 4% （6/28） respectively with median survival period of 26 months. The survival rates of 1,3,5 years from the first operation were 96.4%（27/28）,78.6%（22/28） and 46. 4%（13/28） respectively with median survival period of 56 months. The survival period of one pationt was as long as 45 years. Conclusion The post operative patients of HCC must be carefully followed up and the recurrent tumour should be detected as early as possible. The re-resection of recurrent HCC is the first choice of the treatment and may markedly prolong the survival period of the patient.

关 键 词：肝癌 复发 再手术 

分 类 号：R735.7[医药卫生—肿瘤]